Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic Cancer: global trends, etiology and risk factors. World. J Oncol. 2019;10(1):10–27. https://doi.org/10.14740/wjon1166.

Article  Google Scholar 

Global Cancer Observatory 2020. Date accessed November 15, 2022 [https://gco.iarc.fr/today/data/factsheets/populations/586-pakistan-fact-sheets.pdf].

Devico Marciano N, Kroening G, Dayyani F. BRCA-mutated pancreatic Cancer: from discovery to novel treatment paradigms. Cancers. 2022;14(10):2453. https://doi.org/10.3390/cancers14102453.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kasuga A, Okamoto T, Udagawa S, Mori C, Mie T, Furukawa T, et al. Molecular features and clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. Int J Mol Sci. 2022;23(3) https://doi.org/10.3390/ijms23031205.

Astiazaran-Symonds E, Kim J. A genome-first approach to estimate prevalence of germline pathogenic variants and risk of pancreatic Cancer in select Cancer susceptibility genes. Cancers (Basel). 2022;14(13):3257. https://doi.org/10.3390/cancers14133257.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li S, Silvestri V, Leslie G, Rebbeck TR, Neuhausen SL, Hopper JL, et al. Cancer risks associated with BRCA1 and BRCA2 pathogenic variants. J Clin Oncol. 2022;40(14):1529–41. https://doi.org/10.1200/jco.21.02112.

Article  PubMed  PubMed Central  Google Scholar 

Smith AL, Wong C, Cuggia A, Borgida A, Holter S, Hall A, et al. Reflex testing for germline BRCA1, BRCA2, PALB2, and ATM mutations in pancreatic Cancer: mutation prevalence and clinical outcomes from two Canadian research registries. JCO Precis Oncol. 2018;2:1–16. https://doi.org/10.1200/po.17.00098.

Article  PubMed  Google Scholar 

Chittenden A, Haraldsdottir S, Ukaegbu C, Underhill-Blazey M, Gaonkar S, Uno H, et al. Implementing systematic genetic counseling and multigene germline testing for individuals with pancreatic Cancer. JCO Oncol Pract. 2021;17(2):e236–47. https://doi.org/10.1200/op.20.00678.

Article  PubMed  PubMed Central  Google Scholar 

Hu C, Hart SN, Polley EC, Gnanaolivu R, Shimelis H, Lee KY, et al. Association between inherited germline mutations in Cancer predisposition genes and risk of pancreatic Cancer. JAMA. 2018;319(23):2401–9. https://doi.org/10.1001/jama.2018.6228.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Salo-Mullen EE, O'Reilly EM, Kelsen DP, Ashraf AM, Lowery MA, Yu KH, et al. Identification of germline genetic mutations in patients with pancreatic cancer. Cancer. 2015;121(24):4382–8. https://doi.org/10.1002/cncr.29664.

Article  PubMed  CAS  Google Scholar 

Shindo K, Yu J, Suenaga M, Fesharakizadeh S, Cho C, Macgregor-Das A, et al. Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma. J Clin Oncol. 2017;35(30):3382–90. https://doi.org/10.1200/jco.2017.72.3502.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yin L, Wei J, Lu Z, Huang S, Gao H, Chen J, et al. Prevalence of germline sequence variations among patients with pancreatic Cancer in China. JAMA Netw Open. 2022;5(2):e2148721. https://doi.org/10.1001/jamanetworkopen.2021.48721.

Article  PubMed  PubMed Central  Google Scholar 

Mizukami K, Iwasaki Y, Kawakami E, Hirata M, Kamatani Y, Matsuda K, et al. Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes. EBioMedicine. 2020;60:103033. https://doi.org/10.1016/j.ebiom.2020.103033.

Article  PubMed  PubMed Central  Google Scholar 

Takeuchi S, Doi M, Ikari N, Yamamoto M, Furukawa T. Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma. Sci Rep. 2018;8(1):8105. https://doi.org/10.1038/s41598-018-26526-x.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lee K, Yoo C, Kim KP, Park KJ, Chang HM, Kim TW, et al. Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing. Investig New Drugs. 2018;36(1):163–9. https://doi.org/10.1007/s10637-017-0497-1.

Article  CAS  Google Scholar 

Rashid MU, Zaidi A, Torres D, Sultan F, Benner A, Naqvi B, et al. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. Int J Cancer. 2006;119(12):2832–9. https://doi.org/10.1002/ijc.22269.

Article  PubMed  CAS  Google Scholar 

Rashid MU, Muhammad N, Naeemi H, Khan FA, Hassan M, Faisal S, et al. Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study. Hered Cancer Clin Pract. 2019;17:27. https://doi.org/10.1186/s13053-019-0125-5.

Article  PubMed  PubMed Central  Google Scholar 

Rashid MU, Muhammad N, Naeemi H, Shehzad U, Hamann U. Chasing the origin of 23 recurrent BRCA1 mutations in Pakistani breast and ovarian cancer patients. Int J Cancer. 2022;151(3):402–11. https://doi.org/10.1002/ijc.34016.

Article  PubMed  CAS  Google Scholar 

Muhammad N, Sadaqat R, Naeemi H, Masood I, Hassan U, Ijaz B, et al. Contribution of germline PALB2 variants to an unselected and prospectively registered pancreatic cancer patient cohort in Pakistan. HPB (Oxford). 2022;24(12):2134–44. https://doi.org/10.1016/j.hpb.2022.09.003.

Article  PubMed  Google Scholar 

Rashid MU, Muhammad N, Amin A, Loya A, Hamann U. Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan. Breast Cancer Res Treat. 2017;161(2):191–201. https://doi.org/10.1007/s10549-016-4044-0.

Article  PubMed  CAS  Google Scholar 

Li J, Shi L, Zhang K, Zhang Y, Hu S, Zhao T, et al. VarCards: an integrated genetic and clinical database for coding variants in the human genome. Nucleic Acids Res. 2018;46(D1):D1039–d1048. https://doi.org/10.1093/nar/gkx1039.

Article  PubMed  CAS  Google Scholar 

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24. https://doi.org/10.1038/gim.2015.30.

Article  PubMed  PubMed Central  Google Scholar 

Joseph V, Ravichandran V, Offit K. Pathogenicity of mutation analyzer (PathoMAN): a fast automation of germline genomic variant curation in clinical sequencing. J Clin Oncol. 2017;35(15_suppl):1529-1529. https://doi.org/10.1200/JCO.2017.35.15_suppl.1529.

Article  Google Scholar 

Li Q, Wang K. InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am J Hum Genet. 2017;100(2):267–80. https://doi.org/10.1016/j.ajhg.2017.01.004.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhao Z, Li X. Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. Cancer Med. 2023;12(10):11672–85. https://doi.org/10.1002/cam4.5871.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wieme G, Kral J, Rosseel T. Prevalence of germline pathogenic variants in Cancer predisposing genes in Czech and Belgian pancreatic Cancer patients. Cancers. 2021;13(17):4430. https://doi.org/10.3390/cancers13174430.

Article  PubMed  PubMed Central  Google Scholar 

Fountzilas E, Eliades A. Clinical significance of germline Cancer predisposing variants in unselected patients with pancreatic adenocarcinoma. Cancers (Basel). 2021;13(2):198. https://doi.org/10.3390/cancers13020198.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Peretti U, Cavaliere A, Niger M, Tortora G, Di Marco MC, Rodriquenz MG, et al. Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort. ESMO Open. 2021;6(1):100032. https://doi.org/10.1016/j.esmoop.2020.100032.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cremin C, Lee MK. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening. Cancer Med. 2020;9(11):4004–13. https://doi.org/10.1002/cam4.2973.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Armakolas A, Ladopoulou A, Konstantopoulou I, Pararas B, Gomatos IP, Kataki A, et al. BRCA2 gene mutations in Greek patients with familial breast cancer. Hum Mutat. 2002;19(1):81–2. https://doi.org/10.1002/humu.9003.

Article  PubMed  CAS  Google Scholar 

Purrington KS, Raychaudhuri S. Heritable susceptibility to breast Cancer among African-American women in the Detroit research on Cancer survivors study. Cancer Epidemiol Biomark Prev. 2020;29(11):2369–75. https://doi.org/10.1158/1055-9965.epi-20-0564.

Article  CAS  Google Scholar 

Cavanagh H, Rogers KM. The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers. Hered Cancer Clin Pract. 2015;13(1):16. https://doi.org/10.1186/s13053-015-0038-x.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fradet-Turcotte A, Sitz J, Grapton D, Orthwein A. BRCA2 functions: from DNA repair to replication fork stabilization. Endocr Relat Cancer. 2016;23(10):T1–t17. https://doi.org/10.1530/erc-16-0297.

Article  PubMed  CAS